Tilson: AIG Is No V...
Health Care: Drugs
Insmed Inc. (INSM: NASDAQ)
$10.90 0.34 | 3.22%
05/17/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 0.00 | 4.42M | 6.92M | 10.37M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 0.00 | 4.42M | 6.92M | 10.37M |
| Selling, General, and Administrative Expenses | 12.66M | 12.23M | 10.26M | 9.84M |
| Research & Development | 29.78M | 27.92M | 4.76M | 9.21M |
| Operating Income before D & A (EBITDA) | -42.44M | -35.73M | -8.09M | -8.67M |
| Depreciation & Amortization | 797.00K | 343.00K | 54.00K | 707.00K |
| Interest Income | 1.82M | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 5.00K | 2.06M | 1.84M | 128.28M |
| Special Income / Charges | 0.00 | -25.99M | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -41.41M | -60.00M | -6.30M | 118.90M |
| Interest Expense | 763.00K | 10.00K | 109.00K | 781.00K |
| Pre-Tax Income | -42.17M | -60.01M | -6.41M | 118.12M |
| Income Taxes | 0.00 | 0.00 | 78.00K | 477.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -41.37M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -41.37M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -41.37M | -59.66M | -6.43M | 118.35M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-41.37M | 25.99M | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -41.37M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -1.56 | -2.95 | -0.49 | 9.30 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.56 | -2.95 | -0.49 | 9.30 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.56 | -2.95 | -0.49 | 9.30 |
| Basic Normalized Net Income/Share | -1.56 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -1.56 | -2.95 | -0.49 | 9.30 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.56 | -2.95 | -0.49 | 9.30 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.56 | -2.95 | -0.49 | 9.30 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.56 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with INSM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Userbetterlatethannever
- UserStock Choices
- Userjstanley Portfolio 1
- Userlgselsorlaw Portfolio 1
- Userkazooskibum
- Usersmercado
- UserMr. T fund
- UserLorirain II
Latest INSM Headlines from TheStreet
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
- 4 Plays Under $10 on the Rise 11.13.12 | 05:11 pm
- Insmed's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 01:08 pm
- 5 Under-$10 Stocks Poised for a Breakout 06.07.12 | 02:06 pm
- Insmed Stock Gaps Down On Today's Open (INSM) 10.10.11 | 09:10 am
- Insmed Inc. Stock Downgraded (INSM) 08.22.11 | 08:08 am
- Insmed Stock Soars (INSM) 08.11.11 | 03:08 pm
- 'Strong Rally' in Small-Caps May Emerge 08.09.11 | 10:08 am
- Insmed Stock Gaps Down On Today's Open (INSM) 08.02.11 | 09:08 am
- Insmed Inc. Stock Upgraded (INSM) 07.22.11 | 07:07 am
Press Releases for INSM
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Insmed Incorporated In Connection With Executive Compensation - PR Newswire 01.17.13 | 02:01 pm
- Insmed To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 12.13.12 | 08:12 am
- Insmed Announces CLEAR-108 Phase 3 Clinical Study Of ARIKACE® In Cystic Fibrosis Patients With Pseudomonas Lung Infections Has Completed Target Enrollment - PR Newswire 11.13.12 | 08:11 am
- Insmed To Present At Two Upcoming Investor Conferences - PR Newswire 11.12.12 | 08:11 am
- Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler As Chief Financial Officer - PR Newswire 11.07.12 | 07:11 am
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Insmed To Present At Stifel Nicolaus 2012 Healthcare Conference - PR Newswire 08.30.12 | 08:08 am
- Insmed To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference - PR Newswire 08.14.12 | 08:08 am
- Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors - PR Newswire 08.06.12 | 08:08 am
- Insmed Receives Second Composition Of Matter Patent For ARIKACE® - PR Newswire 08.02.12 | 08:08 am
Partner Headlines for INSM
- Benzinga's Microcap Movers for Friday January 20, 2012 - Benzinga 01.22.12 | 10:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BMS Drug Deemed Too Costly: Weekly Round-Up Of Biotech Failures And Mishaps - Seeking Alpha 10.16.11 | 08:10 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Thursday's Top Performing Small Cap Stocks (AONE, AIQ, KV.A, INSM, CXPO) - NASDAQ 08.12.11 | 03:08 pm
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Portfolio Moves in a Volatile Market - Seeking Alpha 05.09.10 | 05:05 am
